正念干预对新诊断高级别胶质瘤患者可行性的临床试验
该研究评估正念干预在新诊断WHO 3-4级恶性胶质瘤患者同步放化疗期间可行性。干预为6次每周1小时电话正念课程加1次面对面课程,15例参与,平均出席率82.86%,70%完成访谈者愿继续练习。结论为干预可行。
要点
- 同步放化疗期间电话正念干预对高级别胶质瘤患者可行。
- 患者平均出席率82.86%,完成访谈者70%愿继续练习。
- 完成全部7次课程者中超过50%认为课程有益。
核心结论
- 高级别胶质瘤患者主动治疗期间进行正念干预是可行的。
研究设计与样本
- 单臂可行性临床试验,纳入新诊断WHO 3-4级恶性胶质瘤患者。
- 干预为6次每周1小时电话正念课程加1次面对面课程,与标准放化疗同步。
- 可行性从可接受性、需求和实施三个域评估,用标准化患者报告结局问卷测量生活质量。
主要发现
- 四个月内27例患者被提供参与机会,其中15例参与。
- 入组中位年龄60岁(范围28-76岁),女性占73.3%,白人占100%。
- 患者平均出席课程比例为82.86%(SD=28.16)。
- 完成退出访谈的10例中70%表示会继续练习正念。
- 完成全部7次课程的患者中超过50%认为课程有益。
临床怎么用
- 可考虑在高级别胶质瘤患者同步放化疗期间提供电话正念干预。
- 电话课程出席率较高,可作为非药物支持策略探索。
局限性
- 样本量小(15例参与),仅为可行性研究。
- 入组人群以女性(73.3%)和白人(100%)为主,代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: With a bleak prognosis for malignant glioma, maintaining quality of life (QoL) and decreasing distress are essential in patient clinical care. Mindfulness meditation is a mind-body therapy that is being investigated as a non-pharmacological strategy to alleviate cancer symptoms and improve QoL. Given the potential of this intervention, we hypothesized that mindfulness meditation is feasible and may benefit patients with brain tumors on active therapy by decreasing stress and anxiety. METHODS: Patients with newly diagnosed WHO grade 3-4 malignant glioma were enrolled to evaluate the feasibility of a mindfulness intervention that coincided with standard of care chemoradiation. The intervention consisted of six weekly one-hour telephone-based mindfulness sessions followed by one in-person mindfulness session. QoL was measured by standardized patient-reported outcome questionnaires pre- and post-intervention. Feasibility was assessed within three domains: acceptability, demand, and implementation. RESULTS: Over a four-month period, 27 patients were offered the opportunity to participate in this study, of which 15 participated. Median age at enrollment was 60 years (range 28-76 years), with enrollees being predominantly female (73.3%) and white (100%). The average percentage of sessions that the patient attended was 82.86% (SD = 28.16). Of the 10 patients who completed the exit interview, 70% indicated they would continue practicing mindfulness. For patients that attend all seven sessions, >50% of patients found the sessions beneficial. CONCLUSIONS: Mindfulness intervention during active treatment for patients with high grade glioma is feasible. Given these results, a larger study has the potential to benefit patients with high grade glioma on active treatment.
引用
- Ramamurthy K, Randazzo DM, Cort N, et al. Clinical trial of feasibility for mindfulness intervention for patients with newly diagnosed high grade glioma. J Neurooncol. 2025. PMID: 41191167. doi:10.1007/s11060-025-05325-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。